Department of Family Medicine at Laval University in Quebec city, Que.
Can Fam Physician. 2010 Aug;56(8):e308-14.
To assess the reliability and validity of the 4-item SURE (Sure of myself; Understand information; Risk-benefit ratio; Encouragement) screening test for decisional conflict in patients.
Cross-sectional study.
Four family medicine groups in Quebec and 1 rural academic medical centre in New Hampshire.
One hundred twenty-three French-speaking pregnant women considering prenatal screening for Down syndrome and 1474 English-speaking patients referred to watch condition-specific video decision aids.
Cronbach alpha was used to assess the reliability of SURE. A factorial analysis was performed to assess its unidimensionality. The Pearson correlation coefficient was computed between SURE and the Decisional Conflict Scale to assess concurrent validation. A t test procedure comparing the SURE scores of patients who had made decisions with the scores of those who had not was used to assess construct validation.
Among the 123 French-speaking pregnant women, 105 (85%) scored 4 out of 4 (no decisional conflict); 10 (8%) scored 3 (<or= 3 indicates decisional conflict); 7 (6%) scored 2; and 1 (1%) scored 1. Among the 1474 English-speaking treatment-option patients, 981 (67%) scored 4 out of 4; 272 (18%) scored 3; 147 (10%) scored 2; 54 (4%) scored 1; and 20 (1%) scored 0. The reliability of SURE was moderate (Cronbach alpha of 0.54 in French-speaking pregnant women and 0.65 in treatment-option patients). In the group of pregnant women, 2 factors accounted for 72% of the variance. In the treatment-option group, 1 factor accounted for 49% of the variance. In the group of pregnant women, SURE correlated negatively with the Decisional Conflict Scale (r = -0.46; P < .0001); and in the group of treatment-option patients, it discriminated between those who had made a choice for a treatment and those who had not (P < .0001).
The SURE screening test shows promise for screening for decisional conflict in both French- and English-speaking patients; however, future studies should assess its performance in a broader group of patients.
评估 4 项 SURE(对自己有信心;了解信息;风险-效益比;鼓励)筛选测试在患者决策冲突中的可靠性和有效性。
横断面研究。
魁北克的四个家庭医学组和新罕布什尔州的一个农村学术医疗中心。
123 名说法语的孕妇考虑进行唐氏综合征产前筛查,以及 1474 名被转诊观看特定疾病视频决策辅助工具的英语患者。
Cronbach α 用于评估 SURE 的可靠性。进行因子分析以评估其单维性。Pearson 相关系数用于评估 SURE 与决策冲突量表之间的同时验证。t 检验程序用于比较做出决策的患者的 SURE 评分与未做出决策的患者的评分,以评估结构验证。
在 123 名说法语的孕妇中,有 105 名(85%)得分为 4 分(无决策冲突);10 名(8%)得分为 3 分(<=3 分表示决策冲突);7 名(6%)得分为 2 分;1 名(1%)得分为 1 分。在 1474 名接受治疗选择的患者中,有 981 名(67%)得分为 4 分;272 名(18%)得分为 3 分;147 名(10%)得分为 2 分;54 名(4%)得分为 1 分;20 名(1%)得分为 0 分。SURE 的可靠性为中度(说法语的孕妇为 0.54,接受治疗选择的患者为 0.65)。在孕妇组中,2 个因素占方差的 72%。在治疗选择组中,1 个因素占方差的 49%。在孕妇组中,SURE 与决策冲突量表呈负相关(r = -0.46;P<.0001);在治疗选择患者组中,它区分了已经做出治疗选择的患者和未做出选择的患者(P<.0001)。
SURE 筛选测试在说法语和英语患者中均显示出用于筛选决策冲突的潜力;然而,未来的研究应该在更广泛的患者群体中评估其性能。